Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis

Journal of Clinical Laboratory Analysis

Volumn 19, Issue 5, 2005, Pages 189-195

  Palomo, Iván ^a   Pereira, Jaime ^b   Alarcón, Marcelo ^a   Díaz, Gonzalo ^c   Hidalgo, Patricia ^b   Pizarro, Isabel ^b   Jara, Eric ^a   Rojas, Patricio ^a   Quiroga, Guillermo ^a   Moore Carrasco, Rodrigo ^a  

^a UNIVERSIDAD DE TALCA   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c HOSPITAL REGIONAL DE TALCA   (Chile)

Author keywords

Fc RIIa; Hemodialysis; Heparin induced antibodies

Indexed keywords

ANTIBODY; FC GAMMA RECEPTOR IIA; FC RECEPTOR; HEPARIN; HEPARIN INDUCED ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; THROMBOCYTE FACTOR 4; THROMBOCYTE FACTOR 4 HEPARIN COMPLEX; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTERIOVENOUS FISTULA; ARTICLE; BIOASSAY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SEROTONIN RELEASE; SEROTONIN RELEASE ASSAY; THROMBOCYTOPENIA; THROMBOSIS;

ADULT; AGED; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, CD; ARTERIOVENOUS FISTULA; FEMALE; HEPARIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RENAL DIALYSIS; THROMBOCYTOPENIA; THROMBOSIS;

FISTULA;

EID: 26044449320     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.20076     Document Type: Article

References (34)

1. Greinacher A. Heparin-induced thrombocytopenia: pathophysiology and clinical concerns. Baillieres Clin Haematol 1998;11: 461-474.
2. Warkentin TE. Heparin-induced thrombocytopenia: a ten-year retrospective. Annu Rev Med 1999;50:129-147.
3. Cadroy Y, Amiral J, Raynaud H, et al. Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin-induced thrombocytopenia reexposed to heparin. Thromb Haemost 1994; 72:783-784.
4. Chong BH, Pitney WR, Castaldi PA. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation. Lancet 1982;2:1246-1249.
5. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992;68:95-96.
6. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93:81-88.
7. Blank M, Shoenfeld Y, Tavor S, et al. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol 2002;14:121-129.
8. Burgess JK, Lindeman R, Chesterman CN, Chong BH. Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 1995;91:761-766.
9. Arepally G, McKenzie SE, Jiang XM, Poncz M, Cines DB. Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood 1997;89:370-375.
10. Warmerdam PA, Parren PW, Vlug A, Aarden LA, van de Winkel JG, Capel PJ. Polymorphism of the human Fc gamma receptor II (CD32): molecular basis and functional aspects. Immunobiology 1992;185:175-182.
11. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 1991;147:1338-1343.
12. Brandt JT, Isenhart CE, Osborne JM, Ahmed A, Anderson CL. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia. Thromb Haemost 1995;74:1564-1572.
13. Palomo I, Pereira J, Alarcón M, et al. Anticuerpos antiplaquetarios inducidos por heparina: prevalencia en patientes portadores de Enfermedad Renal Crónica en hemodiálisis. Rev Chil Cancer Hematol 1998;8:73-78.
14. Yamamoto S, Koide M, Matsuo M, et al. Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 1996;28:82-85.
15. Sitter T, Spannagl M, Banas B, Schiffl H. Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients. Nephron 1998;79:245-246.
16. Luzzatto G, Bertoli M, Cella G, Fabris F, Zaia B, Girolami A. Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis. Thromb Res 1998;89:115-122.
17. Arepally G, Reynolds C, Tomaski A, et al. Comparison of PF4/ heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1995;104:648-654.
18. Rucinski B, Niewiarowski S, James P, Walz DA, Budzynski AZ. Antiheparin proteins secreted by human platelets, purification, characterization, and radioimmunoassay. Blood 1979;53:47-62.
19. Kelton JG, Sheridan D, Brain H, Powers PJ, Turpie AG, Carter CJ. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 1984;103:606-612.
20. Flesch BK, Bauer F, Neppert J. Rapid typing of the human Fc gamma receptor IIA polymorphism by polymerase chain reaction amplification with allele-specific primers. Transfusion 1998; 38:174-176.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
22. Greinacher A. The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia. Semin Thromb Hemost 2004;30:315-327.
23. Hourigan LA, Walters DL, Keck SA, Dec GW. Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients. J Heart Lung Transplant 2002;21: 1283-1289.
24. Amiral J, Wolf M, Fischer A, Boyer-Neumann C, Vissac A, Meyer D. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 1996;92:954-959.
25. Tazzari PL, Ricci F, Vitale M, et al. Heparin-induced thrombocytopenia: detection of antiheparin/PF4 antibodies by means of heparin/PF4-coated beads and flow cytometry. Transfus Med 2002;12:193-198.
26. Newman PM, Chong BH. Further characterization of antibody and antigen in heparin-induced thrombocytopenia. Br J Haematol 1999;107:303-309.
27. Gerotziafas GT, Elalamy I, Lecrubier C, et al. The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 2001;12:511-520.
28. Untch B, Ahmad S, Jeske WP, et al. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG. Thromb Res 2002;105:117-123.
29. Cines DB, Kaywin P, Bina M, Tomaski A, Schreiber AD. Heparin-associated thrombocytopenia. N Engl J Med 1980;303: 788-795.
30. Greinacher A, Zinn S, Wizemann, Birk UW. Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis. Lancet 1996; 348:764.
31. Carlsson LE, Santoso S, Baurichter G, et al. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood 1998;92:1526-1531.
32. Anderson CL, Chacko GW, Osborne JM, Brandt JT. The Fc receptor for immunoglobulin G (Fc gamma RII) on human platelets. Semin Thromb Hemost 1995;21:1-9.
33. Opatrny Jr K. Hemostasis disorders in chronic renal failure. Kidney Int Suppl 1997;62:S87-S89.
34. Farid FA, Faheem MS, Heshmat NM, Shaheen KY, Saad SS. Study of the homocysteine status in children with chronic renal failure. Am J Nephrol 2004;24:289-295.